| Application no. and date | 19739766.4 (espacenet) (Federated) (European Patent Register), 20190614 | | Patent/reg. no. and date | DK/EP 3810201, 20230607 | | Publication date | 20210428 | | Priority no. and date | US 201862688632 P, 20180622 | | EP pub. no. and date |
EP 3810201 20210428 | | Effective date | | | Applicant/owner | Eli Lilly and Company, Lilly Corporate Center
Indianapolis, IN 46285, US | | Applicant ref. no. | V460363DK00 | | Inventor | CORVARI, Vincent John, c/o Eli Lilly and Company P.O. Box 6288
Indianapolis, Indiana 46206-6288, US,
MINIE, Christopher Sears, c/o Eli Lilly and Company P.O. Box 6288
Indianapolis, Indiana 46206-6288, US,
MISHRA, Dinesh Shyandeo, c/o Eli Lilly and Company P.O. Box 6288
Indianapolis, Indiana 46206-6288, US,
QIAN, Ken Kangyi, c/o Eli Lilly and Company P.O. Box 6288
Indianapolis, Indiana 46206-6288, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 38/26 (2006.01) , A61K 47/02 (2006.01) , A61K 47/10 (2017.01) , A61P 3/10 (2006.01) | | Title | GIP/GLP1-agonist-sammensætninger | | Int. application no. | US2019037146 | | Int. publication no. | WO2019245893 | | Related patent (certificate) | | | Status | Rettet DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
